Asian Pacific Society of Prion Research (APSPR)

Asian Pacific Society of Prion Research (APSPR)

News

●New President and Vice-President
・ Dr. Motohiro Horiuchi of Hokkaido University has become new President
of APSPR.
・ Dr. Noriyuki Nishida of Nagasaki University has become new Vice-President
of APSPR.

●New Honorary Member
・ Dr. Yong-Sun Kim of the Ilsong Institute of Life Science, Hallym University,
Korea has become new Honorary Member.

●APPS2017 and Future Meetings
・ APPS2017 Melbourne hosted by Prof. Steven John Collins was successfully
closed on October 21, thanks to the efforts of Prof. Collins, the local
staff, and the members who participated.
・ APPS2018 will be held on October 4th (Thu) – 5th (Fri), 2018 at Tokyo,
Japan by Dr. Naomi Hachiya of Tokyo Metropolitan Industrial Technology
Research Institute.
・ APPS2019 will be held at Saitama, Japan by Dr. Motomasa Tanaka of RIKEN
Brain Science Institute.
・ APPS2020 will be held at Beijing, China Dr. Xiao-Ping Dong of National
Institute for Viral Disease Control and Prevention, China CDC.

(Updated on November 9, 2017)

Asian Pacific Society of Prion Research (APSPR)

We have experienced over the last 20 years that prion diseases pose major
threats to food safety through the prevalence of bovine spongiform encephalopathy
(BSE) and the occurrence of variant Creutzfeldt-Jakob disease. We also
have recognized again that prion diseases pose important threats to medical
safety because of the frequent occurrence of Creutzfeldt-Jakob disease
associated with dura mater transplantation. Marked progress has been made
in the last 20 years in the elucidation of the pathology of prion diseases
as well as prion formation mechanisms, the development of diagnostic technologies
for prions, and the development of technologies for prion inactivation.
However, a long period of progress may unfold before prion diseases can
be overcome.

The disease occurs sporadically in most human patients, although the causes and predisposition to susceptibility remain to be known. Basic studies of therapeutic and preventive measures have been actively undertaken, but neither measures to prevent disease onset nor feasible measures to halt the progress of the disease completely have been discovered. In animals, prion disease (chronic wasting disease) is still prevalent in fee-ranging deer and elk, which are therefore difficult to contain. Whereas typical BSE has been nearly exterminated in cattle because regulations on feed worked, atypical types of BSE still occur sporadically. Scrapie has been tried to be overcome by bleeding sheep with the scrapie-resistant genotypes, although atypical scrapie occurs in such sheep.

Phenomena similar to prions have been identified in the pathogenic proteins of various other neurodegenerative diseases and amyloidoses, expanding the prion concept. It has not been concluded whether the pathogenic proteins of these diseases also threaten food safety or medical safety in the same way that prions do, although it poses a very important question. Because the morbidity of these diseases increases along with aging, the diseases can pose severe difficulties for medical safety in countries with aging populations.

The earnest hope of the APSPR is that a new breakthrough will be born from more active information exchange and joint studies via close interaction of many researchers throughout the Asian Pacific region who are interested in prion and prion-like phenomena. We also sincerely wish that the APSPR will be the place for the exchange of many young-generation researchers supporting the conquest of these diseases. For these purposes, the APSPR aims to be the platform of the Asian Pacific region to contribute to the progress of research, education, diagnosis, and medical care for fields in which prion and prion-like proteins are involved. We hope that concerned persons will make good use of the APSPR in equal partnership, transcending the constraints imposed by field designations and national boundaries.